Live: Will Micron Crush Q3 Earnings Tonight After Tuesday’s 13% Selloff?

Investing

AbbVie : ABBV

All AbbVie Articles

601 Articles

Jon C. Ogg | Oct 16, 2013 at 11:20 AM EDT

New IPO ETF Certain to Gain Traction, More IPO ETF Competition

ThinkstockThe saying is that if there is a trading strategy, then there is an ETF strategy for that as well.…

Jon C. Ogg | Oct 9, 2013 at 8:15 AM EDT

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

ThinkstockThe drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week’s government shutdown…

Jon C. Ogg | Oct 2, 2013 at 12:25 PM EDT

Spin-Offs Back in Vogue: Six Must-Watch Special Situations

ThinkstockWhen the markets go through periods of great gains, it is not uncommon to see companies start to take more…

Lee Jackson | Sep 16, 2013 at 8:45 AM EDT

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

ThinkstockInvestors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the…

Jon C. Ogg | Jun 6, 2013 at 8:00 AM EDT

Jefferies Raises Price Targets on Pharmaceutical Stocks to Buy

ThinkstockAs the pharmaceuticals industry looks toward restructuring and separation of undervalued assets, Jefferies analysts have prepared a highly proprietary sum…

Jon C. Ogg | May 14, 2013 at 7:50 AM EDT

Merrill Lynch Large Cap Pharmaceutical Stocks to Buy

ThinkstockOne of the downsides to a market that seems to go up every day is knowing what stocks to own…

Paul Ausick | Apr 26, 2013 at 8:30 AM EDT

AbbVie Reports First Earnings Since IPO

ThinkstockAbbVie Inc. (NYSE: ABBV) reported first-quarter 2013 results before markets opened this morning. The pharmaceutical research firm posted adjusted diluted…

Paul Ausick | Apr 22, 2013 at 4:03 PM EDT

24/7 Wall St. Closing Bell — April 22, 2013: Markets Close Higher After Rocky Start

U.S. equity markets opened higher this morning, but struggled to stay in positive territory for most of the morning. There…

Jon C. Ogg | Apr 22, 2013 at 8:15 AM EDT

Top Analyst Upgrades and Positive Views from Wall Street

Investors and traders are on the lookout for fresh research ideas from Wall St. that will lead to higher income…

Jon C. Ogg | Apr 11, 2013 at 8:20 AM EDT

Jefferies Gets Bullish on Pharma with Higher Targets (ABBV, ABT, BMY, PFE, ZTS, LLY, GSK, MRK, JEF)

ThinkstockWith the markets making new highs seemingly every day, it is understandable that investors may be finding it harder and…

Paul Ausick | Feb 7, 2013 at 4:02 PM EST

24/7 Wall St. Closing Bell — February 7, 2013: Markets Flat to Start, Then Slide (BBRY, MCP, NOK, ABBV, GOOG, FMC, GMCR, IACI, TSO, V, YELP, ALU, BG, CI, MWW, NYT, PM, S, TEVA, ATVI, CSTR, LNKD, RVBD, SPWR, AOL, APO, MCO, XONE, SUTR, AKAM)

U.S. equity markets opened flat this morning, largely due to a slew of data from Europe that essentially cancelled any…

Jon C. Ogg | Feb 7, 2013 at 8:35 AM EST

Credit Suisse Grows Cautious on Some Big Health Care Stocks (PFE, JNJ, SYK, ABBV)

ThinkstockHave some widely owned health care names hit a wall when it comes to growth and earnings? In a research…

Jon C. Ogg | Feb 7, 2013 at 8:20 AM EST

Top Analyst Upgrades and Downgrades (ABBV, AKAM, BBRY, COCO, DV, GOOG, HLF, JNJ, JCP, MCP, NOK, PFE, SLW, SYK, TE, VCLK, V)

Jon OggThese are some of this Thursday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. AbbVie Inc.…

Jon C. Ogg | Jan 25, 2013 at 11:11 AM EST

BofA Merrill Lynch: Three Reasons to Own Stocks Now (GSK, BMY, SNY, ABBV, PM, MSFT, INTC, BP, KRFT, GE)

Stocks have rallied sharply during January after the last-minute congressional compromise on the fiscal cliff. While the deal was far…

Jon C. Ogg | Jan 17, 2013 at 8:29 AM EST

Jefferies Top Global Pharmaceutical Stock Picks for 2013 (JEF, ABBV, NVS, SNY, PFE)

ThinkstockAfter a strong year of relative performance for pharmaceutical stocks in 2012, the analysts at Jefferies Group Inc. (NYSE: JEF)…

1 … 38 39 40 41

AbbVie : ABBV

All AbbVie Articles

New IPO ETF Certain to Gain Traction, More IPO ETF Competition

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

Spin-Offs Back in Vogue: Six Must-Watch Special Situations

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

Jefferies Raises Price Targets on Pharmaceutical Stocks to Buy

Merrill Lynch Large Cap Pharmaceutical Stocks to Buy

AbbVie Reports First Earnings Since IPO

24/7 Wall St. Closing Bell — April 22, 2013: Markets Close Higher After Rocky Start

Top Analyst Upgrades and Positive Views from Wall Street

Jefferies Gets Bullish on Pharma with Higher Targets (ABBV, ABT, BMY, PFE, ZTS, LLY, GSK, MRK, JEF)

24/7 Wall St. Closing Bell — February 7, 2013: Markets Flat to Start, Then Slide (BBRY, MCP, NOK, ABBV, GOOG, FMC, GMCR, IACI, TSO, V, YELP, ALU, BG, CI, MWW, NYT, PM, S, TEVA, ATVI, CSTR, LNKD, RVBD, SPWR, AOL, APO, MCO, XONE, SUTR, AKAM)

Credit Suisse Grows Cautious on Some Big Health Care Stocks (PFE, JNJ, SYK, ABBV)

Top Analyst Upgrades and Downgrades (ABBV, AKAM, BBRY, COCO, DV, GOOG, HLF, JNJ, JCP, MCP, NOK, PFE, SLW, SYK, TE, VCLK, V)

BofA Merrill Lynch: Three Reasons to Own Stocks Now (GSK, BMY, SNY, ABBV, PM, MSFT, INTC, BP, KRFT, GE)

Jefferies Top Global Pharmaceutical Stock Picks for 2013 (JEF, ABBV, NVS, SNY, PFE)

Live: Will Micron Crush Q3 Earnings Tonight After Tuesday’s 13% Selloff?

Only 30% of Americans Ever Receive an Inheritance. Those Who Do Get It at 58, Not 30.

Why I Can’t Stop Buying This Unstoppable Dividend Juggernaut

Coinbase Could Jump 65% as Crypto Recovery Unfolds

Only 30% of Americans Ever Receive an Inheritance. Those Who Do Get It at 58, Not 30.

Enroll in Medicare at 65 While Still Working and Your HSA Deposits Turn Into a 6% Penalty

Only 30% of Americans Ever Receive an Inheritance. Those Who Do Get It at 58, Not 30.

Why I Can’t Stop Buying This Unstoppable Dividend Juggernaut

AbbVie : ABBV

All AbbVie Articles

New IPO ETF Certain to Gain Traction, More IPO ETF Competition

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

Spin-Offs Back in Vogue: Six Must-Watch Special Situations

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

Jefferies Raises Price Targets on Pharmaceutical Stocks to Buy

Merrill Lynch Large Cap Pharmaceutical Stocks to Buy

AbbVie Reports First Earnings Since IPO

24/7 Wall St. Closing Bell — April 22, 2013: Markets Close Higher After Rocky Start

Top Analyst Upgrades and Positive Views from Wall Street

Jefferies Gets Bullish on Pharma with Higher Targets (ABBV, ABT, BMY, PFE, ZTS, LLY, GSK, MRK, JEF)

24/7 Wall St. Closing Bell — February 7, 2013: Markets Flat to Start, Then Slide (BBRY, MCP, NOK, ABBV, GOOG, FMC, GMCR, IACI, TSO, V, YELP, ALU, BG, CI, MWW, NYT, PM, S, TEVA, ATVI, CSTR, LNKD, RVBD, SPWR, AOL, APO, MCO, XONE, SUTR, AKAM)

Credit Suisse Grows Cautious on Some Big Health Care Stocks (PFE, JNJ, SYK, ABBV)

Top Analyst Upgrades and Downgrades (ABBV, AKAM, BBRY, COCO, DV, GOOG, HLF, JNJ, JCP, MCP, NOK, PFE, SLW, SYK, TE, VCLK, V)

BofA Merrill Lynch: Three Reasons to Own Stocks Now (GSK, BMY, SNY, ABBV, PM, MSFT, INTC, BP, KRFT, GE)

Jefferies Top Global Pharmaceutical Stock Picks for 2013 (JEF, ABBV, NVS, SNY, PFE)

Live: Will Micron Crush Q3 Earnings Tonight After Tuesday’s 13% Selloff?

Only 30% of Americans Ever Receive an Inheritance. Those Who Do Get It at 58, Not 30.

Why I Can’t Stop Buying This Unstoppable Dividend Juggernaut

Coinbase Could Jump 65% as Crypto Recovery Unfolds

Featured Reads

Only 30% of Americans Ever Receive an Inheritance. Those Who Do Get It at 58, Not 30.

Enroll in Medicare at 65 While Still Working and Your HSA Deposits Turn Into a 6% Penalty